No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children

Show full item record



Permalink

http://hdl.handle.net/10138/327525

Citation

Melén , K , Jalkanen , P , Kukkonen , J P , Partinen , M , Nohynek , H , Vuorela , A , Vaarala , O , Freitag , T L , Meri , S & Julkunen , I 2020 , ' No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children ' , Journal of translational autoimmunity , vol. 3 , 100055 . https://doi.org/10.1016/j.jtauto.2020.100055

Title: No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children
Author: Melén, Krister; Jalkanen, Pinja; Kukkonen, Jyrki P.; Partinen, Markku; Nohynek, Hanna; Vuorela, Arja; Vaarala, O.; Freitag, Tobias L.; Meri, Seppo; Julkunen, Ilkka
Contributor: University of Helsinki, Department of Pharmacology
University of Helsinki, Department of Neurosciences
University of Helsinki, HUS Children and Adolescents
University of Helsinki, Immunobiology Research Program
University of Helsinki, HUSLAB
Date: 2020
Language: eng
Number of pages: 11
Belongs to series: Journal of translational autoimmunity
ISSN: 2589-9090
URI: http://hdl.handle.net/10138/327525
Abstract: Narcolepsy type 1, likely an immune-mediated disease, is characterized by excessive daytime sleepiness and cataplexy. The disease is strongly associated with human leukocyte antigen (HLA) DQB1∗06:02. A significant increase in the incidence of childhood and adolescent narcolepsy was observed after a vaccination campaign with AS03-adjuvanted Pandemrix influenza vaccine in Nordic and several other countries in 2010 and 2011. Previously, it has been suggested that a surface-exposed region of influenza A nucleoprotein, a structural component of the Pandemrix vaccine, shares amino acid residues with the first extracellular domain of the human OX2 orexin/hypocretin receptor eliciting the development of autoantibodies. Here, we analyzed, whether H1N1pdm09 infection or Pandemrix vaccination contributed to the development of autoantibodies to the orexin precursor protein or the OX1 or OX2 receptors. The analysis was based on the presence or absence of autoantibody responses against analyzed proteins. Entire OX1 and OX2 receptors or just their extracellular N-termini were transiently expressed in HuH7 cells to determine specific antibody responses in human sera. Based on our immunofluorescence analysis, none of the 56 Pandemrix-vaccinated narcoleptic patients, 28 patients who suffered from a laboratory-confirmed H1N1pdm09 infection or 19 Pandemrix-vaccinated controls showed specific autoantibody responses to prepro-orexin, orexin receptors or the isolated extracellular N-termini of orexin receptors. We also did not find any evidence for cell-mediated immunity against the N-terminal epitopes of OX2. Our findings do not support the hypothesis that the surface-exposed region of the influenza nucleoprotein A would elicit the development of an immune response against orexin receptors. © 2020 The Authors
Subject: Autoimmunity
Influenza A virus nucleoprotein
Narcolepsy
OX1
OX2
Pandemrix vaccination
autoantibody
epitope
influenza vaccine
orexin
orexin 1 receptor
orexin 2 receptor
ribonucleoprotein antibody
adolescent
adult
amino terminal sequence
antibody response
Article
autoimmunity
cellular immunity
child
controlled study
Huh-7 cell line
human
human cell
immunofluorescence
influenza A (H1N1)
influenza vaccination
major clinical study
narcolepsy
priority journal
protein expression
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S2589909020300228_main.pdf 2.707Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record